Scholar Rock Holding Corp - Promising Objective Response Rates (Orr) Were Observed in Multiple Tumor Types in Anti-Pd-(L)1 Resistant Patients
學者巖藥業控股公司 - 在抗PD-(L)1抗藥患者中,多種腫瘤類型的良好客觀反應率(ORR)得到觀察。
Scholar Rock Holding Corp - Promising Objective Response Rates (Orr) Were Observed in Multiple Tumor Types in Anti-Pd-(L)1 Resistant Patients
學者巖藥業控股公司 - 在抗PD-(L)1抗藥患者中,多種腫瘤類型的良好客觀反應率(ORR)得到觀察。
譯文內容由第三人軟體翻譯。